Search research articles
Contact Us
Filters
Showing results (41-50 of 58) with videos related to
Page
of 6
Sort By:
Experimental Neurology
|
June 2, 2000
Quinolinic acid released from polymeric brain implants causes behavioral and neuroanatomical alterations in a rodent model of Huntington's disease
K L Haik, D A Shear, U Schroeder, et al.
Journal of Cognitive Neuroscience
|
April 7, 2005
Transmodal sensorimotor networks during action observation in professional pianists
B Haslinger, P Erhard, E Altenmüller, et al.
Klinische Padiatrie
|
May 10, 2014
Laryngomalacia and complicated, life-threatening mTOR-positive Kaposiform hemangioendothelioma cured by Supraglottoplasty and sirolimus
U Schroeder, M Lauten, G Stichtenoth, et al.
Proceedings. Biological Sciences
|
February 29, 2000
Knowing no fear
R Sprengelmeyer, A W Young, U Schroeder, et al.
Neuropsychologia
|
April 2, 2003
Facial expression recognition in people with medicated and unmedicated Parkinson's disease
R Sprengelmeyer, A W Young, K Mahn, et al.
Plos One
|
October 14, 2017
Functional characterization of GABAA receptor-mediated modulation of cortical neuron network activity in microelectrode array recordings
Benjamin M Bader, Anne Steder, Anders Bue Klein, et al.
Cancer Letters
|
July 26, 2003
Rationally designed hydrolytically activated etoposide prodrugs, a novel strategy for the treatment of neuroblastoma
B Lange, U Schroeder, N Huebener, et al.
Neurotoxicology
|
April 20, 2010
Microelectrode arrays: a physiologically based neurotoxicity testing platform for the 21st century
Andrew F M Johnstone, Guenter W Gross, Dieter G Weiss, et al.
Neuroimage
|
June 6, 2009
Hyperechogenicity of the substantia nigra in healthy controls is related to MRI changes and to neuronal loss as determined by F-Dopa PET
S Behnke, U Schroeder, U Dillmann, et al.
Cancer Letters
|
July 26, 2003
Neuroblastoma directed therapy by a rational prodrug design of etoposide as a substrate for tyrosine hydroxylase
J Jikai, M Shamis, N Huebener, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 58) with videos related to
Sort By:
Page
of 6
Experimental Neurology
|
June 2, 2000
Quinolinic acid released from polymeric brain implants causes behavioral and neuroanatomical alterations in a rodent model of Huntington's disease
K L Haik, D A Shear, U Schroeder, et al.
Journal of Cognitive Neuroscience
|
April 7, 2005
Transmodal sensorimotor networks during action observation in professional pianists
B Haslinger, P Erhard, E Altenmüller, et al.
Klinische Padiatrie
|
May 10, 2014
Laryngomalacia and complicated, life-threatening mTOR-positive Kaposiform hemangioendothelioma cured by Supraglottoplasty and sirolimus
U Schroeder, M Lauten, G Stichtenoth, et al.
Proceedings. Biological Sciences
|
February 29, 2000
Knowing no fear
R Sprengelmeyer, A W Young, U Schroeder, et al.
Neuropsychologia
|
April 2, 2003
Facial expression recognition in people with medicated and unmedicated Parkinson's disease
R Sprengelmeyer, A W Young, K Mahn, et al.
Plos One
|
October 14, 2017
Functional characterization of GABAA receptor-mediated modulation of cortical neuron network activity in microelectrode array recordings
Benjamin M Bader, Anne Steder, Anders Bue Klein, et al.
Cancer Letters
|
July 26, 2003
Rationally designed hydrolytically activated etoposide prodrugs, a novel strategy for the treatment of neuroblastoma
B Lange, U Schroeder, N Huebener, et al.
Neurotoxicology
|
April 20, 2010
Microelectrode arrays: a physiologically based neurotoxicity testing platform for the 21st century
Andrew F M Johnstone, Guenter W Gross, Dieter G Weiss, et al.
Neuroimage
|
June 6, 2009
Hyperechogenicity of the substantia nigra in healthy controls is related to MRI changes and to neuronal loss as determined by F-Dopa PET
S Behnke, U Schroeder, U Dillmann, et al.
Cancer Letters
|
July 26, 2003
Neuroblastoma directed therapy by a rational prodrug design of etoposide as a substrate for tyrosine hydroxylase
J Jikai, M Shamis, N Huebener, et al.
Page
of 6